HR1562-119

Introduced

To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips.

119th Congress Introduced Feb 25, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill expands a grant provision: 2. Grant program for State and Tribal response to opioid use disorders Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended by inserting or fentanyl. It relies on grants. The main policy areas are Healthcare.

Who Benefits and How

The available clause analysis does not identify a specific beneficiary group.

Who Bears the Burden and How

No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.

Key Provisions

  • Expands a grant provision: 2. Grant program for State and Tribal response to opioid use disorders Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended by inserting or fentanyl...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

The bill expands a grant provision: 2. Grant program for State and Tribal response to opioid use disorders Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended by inserting or fentanyl.

Key Policy Areas

Healthcare

Primary Purpose

The bill expands a grant provision: 2. Grant program for State and Tribal response to opioid use disorders Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended by inserting or fentanyl.

Policy Domains

Healthcare

Legislative Progress

Introduced
Introduced Committee Passed
Feb 25, 2025

Ms. Crockett (for herself and Mr. Gooden) introduced the following …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology